Amoy Diagnostics Co., Ltd.
Symbool: 300685.SZ
SHZ
20.6
CNYMarktprijs vandaag
34.8241
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
8.13B
MRK Kapitalisatie
- 0.01%
DIV Rendement
Amoy Diagnostics Co., Ltd. (300685-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0 | 754 | 718.7 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 259.3 | 315.9 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 478.8 | 437.6 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 19.5 | 7.4 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 0 | 1285.1 | 1196 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 208.3 | 209.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | -200.7 | -248.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 6.5 | 20.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 304.5 | 323.1 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 365.8 | 323.9 | ||||||||||||
balance-sheet.row.other-assets | 0 | 1946.5 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 1946.5 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 21.3 | 24 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 5.3 | 3.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 8.8 | 17.1 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 48.3 | 3 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 10.3 | 11.2 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 0 | 0.6 | 0.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0 | 59.2 | 15 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.7 | 3 | ||||||||||||
balance-sheet.row.total-liab | 0 | 0 | 151.2 | 150.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 398.6 | 398.2 | 221.7 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 0 | 827.7 | 637.2 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 3.5 | 91.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1302.5 | 270.4 | 414.1 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1701.1 | 1499.7 | 1364.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 5.1 | ||||||||||||
balance-sheet.row.total-equity | 0 | 1701.1 | 1499.7 | 1369.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 0 | 58.6 | 67.6 | ||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 53.6 | 6.1 | ||||||||||||
balance-sheet.row.net-debt | 0 | 0 | -441 | -396.8 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 256.3 | 264.3 | 239 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 52.3 | 38.9 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | -13.7 | 1.1 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -58.9 | -125.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 25.9 | -132.3 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | -0.6 | -10.8 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | -98 | 19.2 | ||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | -256.3 | -108.6 | 15.4 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 51.9 | 8.9 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -363.6 | -772.1 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 350.2 | 600.7 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -0.5 | -5.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -40.2 | -242.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1.1 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 100.7 | 0 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -100.7 | -4.4 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -51.5 | -55.4 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -68 | 13.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | -120.6 | -46.3 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 24.6 | -10 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 12.9 | -130.8 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 244 | 243.6 | 230.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 244 | 230.7 | 361.6 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 149 | 168.2 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 70.8 | 93.6 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1043.6 | 842.2 | 917 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 147.8 | 143.3 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 1043.6 | 694.4 | 773.8 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 748.4 | 524.3 | 508.9 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 748.4 | 672.1 | 652.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 6.1 | 3.1 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | -32.5 | 52.3 | 38.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 295.1 | 287.7 | 253.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 288.7 | 286.1 | 252 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 32.5 | 21.8 | 13 | ||||||||||||
income-statement-row.row.net-income | 0 | 256.3 | 263.7 | 239.6 |
Vaak gestelde vragen
Wat is Amoy Diagnostics Co., Ltd. (300685.SZ) totale activa?
Amoy Diagnostics Co., Ltd. (300685.SZ) totale activa is 1946538300.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.889.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.246.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.283.
Wat is Amoy Diagnostics Co., Ltd. (300685.SZ) nettowinst (netto-inkomen)?
De nettowinst is 256255700.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 0.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 748437800.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.